Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omacor in Borderline Personality Disorder
NCT00437099Phase 4Unknown
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Feb 2009
- Primary completion
- Feb 2011
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of omega-3-acid triglycerides in borderline personality disorder (BPD), sponsored by Vall d'Hebron Research Institute. Status: unknown.
02
Drugs
omega-3-acid triglycerides
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT00437099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00437099.